Meridian Bioscience Inc.

+0.09 (+0.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)971.61M
Current PE13.85
Forward PE 13.17
2yr Forward PE 16.32
See more stats
Estimates Current Quarter
Revenue$84.48 Million
Adjusted EPS$0.45
See more estimates
10-Day MA$23.39
50-Day MA$24.49
200-Day MA$20.82
See more pivots

Meridian Bioscience Inc. Stock, NASDAQ:VIVO

3471 River Hills Drive, Cincinnati, Ohio 45244
United States of America
Phone: +1.513.271.3700
Number of Employees: 750


Meridian Bioscience, Inc. engages in the development, manufacture, sale, and distribution of diagnostic test kits, antigens, reagents, and related products. It operates through the following segments: Diagnostics and Life Science. The Diagnostics segment consists testing platforms and technologies such as Isothermal DNA Amplification, Rapid Immunoassay, Enzyme-linked Immunoassay, and Anodic Stripping Voltammetry. The Life Science segment distributes bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.